Xencor Inc. Stock
Xencor Inc. Stock
Xencor Inc. dominated the market today, gaining €1.80 (10.650%).
With 15 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 22 € there is a slightly positive potential of 17.65% for Xencor Inc. compared to the current price of 18.7 €.
Pros and Cons of Xencor Inc. in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Xencor Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Xencor Inc. | 10.650% | -1.170% | 19.858% | 125.333% | 33.071% | -21.028% | -34.648% |
| Ligand Pharmaceuticals | -1.540% | -3.759% | -7.246% | 118.803% | 54.217% | 316.260% | 167.056% |
| United Therapeutics | -0.520% | -2.019% | -3.756% | 84.880% | 6.740% | 104.989% | 194.258% |
| Ionis Pharmaceuticals Inc. | 1.430% | -5.964% | -34.579% | 21.707% | -32.019% | 27.978% | 47.510% |
Comments
Xencor (XNCR) had its "outperform" rating reaffirmed by Wedbush. They now have a $26.00 price target on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its price target lowered by Truist Financial Corporation from $29.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat
Xencor (XNCR) had its price target raised by Barclays PLC from $26.00 to $27.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for XNCR provided by MarketBeat